Starpharma Holdings Ltd has released a press release.
Positive DEP phase 2 interim results in prostate cancer
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Story so far
Earlier from Starpharma
- VIRALEZE distribution and supply to Vietnam
- VIRALEZE launch in ADMENTA Italia Group pharmacies in Italy
- VIRALEZE Protects Against SARS-CoV-2 in Challenge Model
- VIRALEZE well tolerated in multiple dose clinical study
- VIRALEZE SPL7013 virucidal against SARS-CoV-2 Delta variant
Later from Starpharma
- AGM Chairman address and CEO presentation
- VIRALEZE registered in Vietnam with launch this week
- VIRALEZE distribution agreement and launch in Vietnam
- Starpharma signs DEP Research Agreement with US Biopharma Co
- VIRALEZE successfully launched in Vietnam
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma